FDA — authorised 13 March 1996
- Marketing authorisation holder: MERCK SHARP DOHME
- Status: approved
🇺🇸 Crixivan in United States
FDA authorised Crixivan on 13 March 1996
Marketing authorisations
FDA — authorised 13 March 1996
- Application: NDA020685
- Marketing authorisation holder: MERCK SHARP DOHME
- Local brand name: CRIXIVAN
- Indication: CAPSULE — ORAL
- Status: approved
Crixivan in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Crixivan approved in United States?
Yes. FDA authorised it on 13 March 1996; FDA authorised it on 13 March 1996.
Who is the marketing authorisation holder for Crixivan in United States?
MERCK SHARP DOHME holds the US marketing authorisation.